The Antimicrobial Resistance Benchmark 2020 scrutinizes drug manufacturer's environmental performance and calls for greater transparency
While many companies now present elaborate environmental strategies and emission targets, none publishes actual antibiotic discharge levels, and none discloses their suppliers of active ingredients or which waste-treatment plants they are using. "Clearly, there is still a long way to go", says Joakim Larsson, director of CARe.